In the latest trading session, Teladoc (TDOC) closed at $5.70, marking a -3.72% move from the previous day. This change lagged the S&P 500's 0.41% loss on the day. Meanwhile, the Dow experienced a drop of 0.36%, and the technology-dominated Nasdaq saw a decrease of 0.89%.
The stock of telehealth services provider has risen by 6.28% in the past month, leading the Medical sector's gain of 0.47% and undershooting the S&P 500's gain of 9.71%.
Market participants will be closely following the financial results of Teladoc in its upcoming release. The company plans to announce its earnings on April 29, 2026. The company's upcoming EPS is projected at -$0.32, signifying a 68.42% drop compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $612.3 million, down 2.71% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of -$0.89 per share and revenue of $2.51 billion, which would represent changes of +21.93% and -0.81%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Teladoc. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Teladoc is currently a Zacks Rank #3 (Hold).
The Medical Services industry is part of the Medical sector. This group has a Zacks Industry Rank of 78, putting it in the top 32% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Teladoc Health, Inc. (TDOC): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).